Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals

Published: Tuesday, November 26, 2013
Last Updated: Monday, November 25, 2013
Bookmark and Share
This year sees strong growth in APIs, biopharma, natural extracts, packaging and finished dosage with a highlight on innovation.

CPhI Worldwide celebrates the closing of its most successful show to date with pre-audit figures estimating more than 34,000 attendees and 2,200 exhibitors.

Held in Frankfurt, the show hosted senior-level decision makers and key players from 140+ countries representing every step of the pharmaceutical supply chain from drug discovery to finished dosage.

On Monday, CPhI Conferences hosted the Pre-Connect with 6 modules on themes including drug delivery systems and biosimilars. The conference featured senior executives and influential industry speakers from Bayer, Novartis and Wockhardt, who leveraged their expertise and insight to educate the industry.

Throughout the week, free content was available in the exhibition with sessions covering Ingredients, Contract Services, Packaging, Animal Health, Biopharma and Natural Extracts, Innovation Tours on biopharma and packaging, and Lunch Briefings on emerging markets of India and Brazil.

With 4 different exhibitions in one (CPhI, P-MEC, InnoPack and ICSE) the event has become the world’s melting pot and key point of the year to complete new deals, see innovative technologies and meet potential partners- attendees say it’s invaluable to the industry.

This year’s event held a record of 17 global pavilions to highlight different countries from each continent- including China, India, USA and Brazil amongst others.

The winners of the 2013 CPhI Pharma Awards were announced, honouring innovation across three categories (Best Innovation in Formulation, Packaging and Process Development) which went to Camurus, E-Pharma Trento and API Corporation, respectively.

Another major addition to this year’s show was the introduction of CPhI Pharma Evolution- a new community website launched in February to help professionals from the pharma industry to share advice from their peers on best-practices and regulatory changes across the pharmaceutical ingredient and contract manufacturing space.

The site features a wealth of stories covering the huge amounts of activity across all four days of the show, including news on all the major initiatives and company news announced. For more information, please visit: www.pharmevolution.com.

CPhI Worldwide and CPhI Pharma Evolution were pleased to release its first Annual Report during the event. Written by a panel of industry experts, the report highlighted key trends including QbD, PAT and six sigma in a series of forward looking articles.

Chris Kilbee, Group Director of CPhI, commented: “This year’s event has been a great success with exhibitors reporting quality meetings and promising business opportunities coming out of the event. We’re pleased to expand our content offering this year with seminars, innovation tours and the release of the first Annual Report. As the pharmaceutical market continues to grow and expand, CPhI will adapt and evolve to deliver industry insights and continue to provide the best platform for developing contacts as the event returns to Paris for its 25th edition from 7–9 October 2014.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

CPhI Korea Opens as South Korea Emerges as Global Leader in Biosimilar Trials
Government’s R&D strategy and “Pharma 2020 Vision” to see country as drug development leader.
Monday, July 27, 2015
CPhI Announces USA Market Report at InformEx
Country report to contain contrasting insights into the American pharma economy from European and domestic perspectives.
Wednesday, January 22, 2014
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
Kilbee responsible for driving the portfolio globally including increased emphasis on digital and content.
Monday, January 13, 2014
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
Growth in the World’s second largest pharma region facilitated by innovation and loosened regulatory guidelines.
Monday, December 30, 2013
John van der Valk Appointed MD of UBM Live Amsterdam
Valk responsible for overseeing the company’s flagship brand CPhI.
Monday, December 23, 2013
Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand
Free online registration to attend CPhI and P-MEC India is now closed.
Tuesday, December 03, 2013
India Sets Ambitious Pharma Export Growth Targets
Indian generics exports growing at 24% per annum.
Monday, October 21, 2013
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!